Updated Jul 16, 2026
Birznieks Gunther is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $351K.
Gunther Birznieks is associated with Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies to address unmet medical needs. Specific details about his role or contributions are not widely documented in public sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-04 | VNDA | Vanda Pharmaceuticals Inc. | S — Open-market sale | 42.4K | $8.27 | $351K |
| 2026-02-19 | VNDA | Vanda Pharmaceuticals Inc. | A — Grant or award | 125.0K | $0.00 |
Gunther Birznieks is associated with Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies to address unmet medical needs. Specific details about his role or contributions are not widely documented in public sources.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($351K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Birznieks Gunther profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.